Skip to main content

Articles

Original Research, Practice Management
Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Ken LaPensee, PhD, MPH; Thomas Lodise, PharmD, PhD
Stakeholder Perspective
Love the Models, Send Me My Data: Conceptual Healthcare Decision Models Informing the Treatment of Acute Bacterial Skin and Skin Structure Infections
Michael F. Murphy, MD, PhD
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Cost-Effectiveness Comparison of Ibrutinib, Chemotherapy, and Chemoimmunotherapy in First-Line Treatment of CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
ECOG-ACRIN Cancer Research Group: Phase 3 Study of Ibrutinib-Based Therapy in Untreated Younger Patients with CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Prognostic Testing and Treatment Approaches in Patients with CLL: Interim Analysis of the informCLL Real-World Registry
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Acalabrutinib in Patients with Relapsed/Refractory and High-Risk, Treatment-Naïve CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Frontline Ibrutinib Treatment Is Associated with Lower Total Cost of Care Compared with Chemoimmunotherapy in Patients with CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Improved MRD Response Rates with Ibrutinib and Obinutuzumab in Patients with CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
MURANO Study Explores Potential for Venetoclax-Rituximab Combination Therapy in Relapsed/Refractory CLL
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Ibrutinib Treatment in Waldenström’s Macroglobulinemia: Follow-Up Efficacy and Safety from the iNNOVATE Study
Read More
ASH 2018 - Chronic Lymphocytic Leukemia
Dual Inhibition of Bruton’s Tyrosine Kinase and BCL2: A Promising Therapeutic Strategy for Myeloid and Lymphoid Leukemias
Read More
Page 62 of 244
Results 611 - 620 of 2436